Back to Search
Start Over
Polygenic risk scores identify heterogeneity in asthma and chronic obstructive pulmonary disease.
- Source :
-
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2023 Dec; Vol. 152 (6), pp. 1423-1432. Date of Electronic Publication: 2023 Aug 16. - Publication Year :
- 2023
-
Abstract
- Background: Asthma and chronic obstructive pulmonary disease (COPD) have distinct and overlapping genetic and clinical features.<br />Objective: We sought to test the hypothesis that polygenic risk scores (PRSs) for asthma (PRS <subscript>Asthma</subscript> ) and spirometry (FEV <subscript>1</subscript> and FEV <subscript>1</subscript> /forced vital capacity; PRS <subscript>spiro</subscript> ) would demonstrate differential associations with asthma, COPD, and asthma-COPD overlap (ACO).<br />Methods: We developed and tested 2 asthma PRSs and applied the higher performing PRS <subscript>Asthma</subscript> and a previously published PRS <subscript>spiro</subscript> to research (Genetic Epidemiology of COPD study and Childhood Asthma Management Program, with spirometry) and electronic health record-based (Mass General Brigham Biobank and Genetic Epidemiology Research on Adult Health and Aging [GERA]) studies. We assessed the association of PRSs with COPD and asthma using modified random-effects and binary-effects meta-analyses, and ACO and asthma exacerbations in specific cohorts. Models were adjusted for confounders and genetic ancestry.<br />Results: In meta-analyses of 102,477 participants, the PRS <subscript>Asthma</subscript> (odds ratio [OR] per SD, 1.16 [95% CI, 1.14-1.19]) and PRS <subscript>spiro</subscript> (OR per SD, 1.19 [95% CI, 1.17-1.22]) both predicted asthma, whereas the PRS <subscript>spiro</subscript> predicted COPD (OR per SD, 1.25 [95% CI, 1.21-1.30]). However, results differed by cohort. The PRS <subscript>spiro</subscript> was not associated with COPD in GERA and Mass General Brigham Biobank. In the Genetic Epidemiology of COPD study, the PRS <subscript>Asthma</subscript> (OR per SD: Whites, 1.3; African Americans, 1.2) and PRS <subscript>spiro</subscript> (OR per SD: Whites, 2.2; African Americans, 1.6) were both associated with ACO. In GERA, the PRS <subscript>Asthma</subscript> was associated with asthma exacerbations (OR, 1.18) in Whites; the PRS <subscript>spiro</subscript> was associated with asthma exacerbations in White, LatinX, and East Asian participants.<br />Conclusions: PRSs for asthma and spirometry are both associated with ACO and asthma exacerbations. Genetic prediction performance differs in research versus electronic health record-based cohorts.<br /> (Published by Elsevier Inc.)
Details
- Language :
- English
- ISSN :
- 1097-6825
- Volume :
- 152
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- The Journal of allergy and clinical immunology
- Publication Type :
- Academic Journal
- Accession number :
- 37595761
- Full Text :
- https://doi.org/10.1016/j.jaci.2023.08.002